These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22990124)

  • 1. Mesoporous systems for poorly soluble drugs.
    Xu W; Riikonen J; Lehto VP
    Int J Pharm; 2013 Aug; 453(1):181-97. PubMed ID: 22990124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
    Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
    Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
    Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
    Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
    Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
    J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs.
    Vialpando M; Martens JA; Van den Mooter G
    Ther Deliv; 2011 Aug; 2(8):1079-91. PubMed ID: 22833866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized mesoporous silica materials for controlled drug delivery.
    Yang P; Gai S; Lin J
    Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous materials and nanocrystals for enhancing the dissolution behavior of poorly water-soluble drugs.
    Santos HA; Peltonen L; Limnell T; Hirvonen J
    Curr Pharm Biotechnol; 2013; 14(10):926-38. PubMed ID: 24372243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends in the stabilization of amorphous drugs.
    Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
    Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
    Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin.
    Li J; Guo Y; Li H; Shang L; Li S
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1085-1094. PubMed ID: 28776393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
    Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
    Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery.
    Heikkilä T; Salonen J; Tuura J; Kumar N; Salmi T; Murzin DY; Hamdy MS; Mul G; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
    Drug Deliv; 2007 Aug; 14(6):337-47. PubMed ID: 17701523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.